Latest Breaking News On - Kinnari patel - Page 1 : comparemela.com

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Kinnari patelGaurav shahRocket pharmaceuticals trading downEarnings history for rocket pharmaceuticalsNeedham companySecurities exchange commissionRocket pharmaceuticalsGoldman sachs groupJpmorgan chase coNews ratings for rocket pharmaceuticals dailyRocket pharmaceuticals incGet free reportPharmaceuticals trading downExchange commissionRocket pharmaceuticals daily

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0 01 EPS

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0 01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kinnari patelDavidp southwellRocket pharmaceuticals incNews ratings for rocket pharmaceuticals dailyJpmorgan chase coGoldman sachs groupSecurities exchange commissionRocket pharmaceuticalsEarnings history for rocket pharmaceuticalsCantor fitzgeraldRocket pharmaceuticals stock performanceRocket pharmaceuticals company profileGet free reportExchange commissionDirector davidRocket pharmaceuticals daily

Rocket Pharmaceuticals (NASDAQ:RCKT) Receives New Coverage from Analysts at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report published on Tuesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $39.00 price target on the biotechnology company’s stock. RCKT has been the topic of several other reports. UBS Group cut their price objective […]

Kinnari patelGotham makkerJpmorgan chase coSteward partners investment advisoryAnalyst recommendations for rocket pharmaceuticalsWells fargo companyLife insurance coChina universal asset management coRocket pharmaceuticals incNeedham companyAdvisor group holdings incRocket pharmaceuticalsGoldman sachs groupRocket pharmaceuticals stock downInstitutional investors weigh in on rocket pharmaceuticalsNews ratings for rocket pharmaceuticals daily

China Universal Asset Management Co Ltd Raises Stake in Rocket Pharmaceuticals, Inc (NASDAQ:RCKT)

China Universal Asset Management Co. Ltd. boosted its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 404.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,424 shares of the biotechnology company’s stock after buying an […]

United statesJohn militelloKinnari patelAsset management americas corpRocket pharmaceuticals price performanceSecurities exchange commissionJpmorgan chase coAllspring global investments holdingsExchange commissionChina universal asset management coNews ratings for rocket pharmaceuticals dailyNeedham companyQuarter for rocket pharmaceuticalsRocket pharmaceuticals incRocket pharmaceuticalsMetlife investment management

Rocket Pharmaceuticals (RCKT) Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia

Rocket Pharmaceuticals (RCKT) Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kinnari patelDrug administrationEuropean medicines agencyRocket pharmaceuticals incRocket pharmaceuticalsMarketing authorization applicationFanconi anemiaChief operating officerBiologics license application